Evidence map›Paper›PMID 35422002›Full record

Trial reportCritical care (London, England)2022

Closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen: a randomized cross-over study (the HILOOP study).

Oriol Roca, Oriol Caritg, Manel Santafé, Francisco J Ramos, Andrés Pacheco, Marina García-de-Acilu, Ricard Ferrer, Marcus J Schultz, Jean-Damien Ricard

3 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04965844 nacompletednot on this map

Safety and Efficacy of a Closed-loop Oxygen Control for High Flow Nasal Therapy in ICU Patients: a Randomized Cross-over Study (The HILOOP Study)

TypeinterventionalSponsorHospital Universitari Vall d'Hebron Research InstituteRan2021 to 2021Enrolled53ConditionsHigh Flow Nasal Cannula, Oxygen Therapy, Hypoxemia, HyperoxemiaArmsOxygen close-loop, No intervention
NCT06374589 narecruitingnot on this mapstarted 2024, after this paper: background citation

Closed-Loop O2 Use During High Flow Oxygen Treatment of Critical Care Adult Patients (CLOUDHFOT)- a Randomized Cross-over Study

TypeinterventionalSponsorBaşakşehir Çam & Sakura City HospitalRan2024 to 2026Enrolled50ConditionsAcute Hypoxemic Respiratory Failure, Acute Hypercapnic Respiratory Failure, Respiratory Depression, Respiratory FailureArmsClosed-loop FiO2 controller, Conventional
NCT06655805 recruitingnot on this mapstarted 2024, after this paper: background citation

Registry for Automated Mechanical VEntilation in Adults

Typeobservational_patient_registrySponsorHamilton Medical AGRan2024 to 2030Enrolled1,000ConditionsRespiratory Insufficiency Requiring Mechanical VentilationArmsNon-invasive ventilation, Invasive mechanical ventilation, high-flow nasal oxygen
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Manual compared to automated closed-loop oxygen control strategies in hospitalised adults: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Effect of automated titration of oxygen on time spent in a prescribed oxygen saturation range in adults in the ICU after cardiac surgery.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 5 countries.

Oriol RocaServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron and Institut de Recerca Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain. oroca@vhebron.net.ORCID 0000-0003-3841-4551
Oriol CaritgServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron and Institut de Recerca Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Manel SantaféServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron and Institut de Recerca Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Francisco J RamosServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron and Institut de Recerca Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Andrés PachecoServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron and Institut de Recerca Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Marina García-de-AciluServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron and Institut de Recerca Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Ricard FerrerServei de Medicina Intensiva, Hospital Universitari Vall d'Hebron and Institut de Recerca Vall d'Hebron, Pg Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Marcus J SchultzDepartment of Intensive Care, Amsterdam University Medical Centers, Location 'AMC', Amsterdam, The Netherlands.
Jean-Damien RicardService de Médecine Intensive Réanimation, DMU ESPRIT, Hôpital Louis Mourier, APHP, Université Paris Cité, Colombes, France.
Vall d'Hebron Institut de Recerca · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESInserm · FRMahidol University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to assess the efficacy of a closed-loop oxygen control in critically ill patients with moderate to severe acute hypoxemic respiratory failure (AHRF) treated with high flow nasal oxygen (HFNO).

methodsIn this single-centre, single-blinded, randomized crossover study, adult patients with moderate to severe AHRF who were treated with HFNO (flow rate ≥ 40 L/min with FiO

resultsForty-five patients were included. Patients spent more time in the optimal SpO

conclusionsClosed-loop oxygen control improves oxygen administration in patients with moderate-to-severe AHRF treated with HFNO, increasing the percentage of time in the optimal oxygenation range and decreasing the workload of healthcare personnel. These results are especially relevant in a context of limited oxygen supply and high medical demand, such as the COVID-19 pandemic. Trial registration The HILOOP study was registered at www. CLINICALTRIALS: gov under the identifier NCT04965844 .

Indexed as

COVID-19Respiratory InsufficiencyAdultCannulaCross-Over StudiesHumansHypoxiaOxygenOxygen Inhalation TherapyPandemicsOxygenAcute respiratory failureAutomatic oxygen titrationClosed-loop oxygen controlHigh flow nasal cannulaHigh-flow nasal oxygenNasal high-flow

Identifiers

PMID35422002
PMCPMC9008383
OpenAlexW4223897615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.